{"resourceType":"Observation","id":"1d36e7b9-0684-5382-b02f-05843fbb1bbe","meta":{"versionId":"1","lastUpdated":"2022-05-24T18:10:44.820-04:00","source":"#T46RlOABR4ejKojw","profile":["http://fhir.mimic.mit.edu/StructureDefinition/mimic-observation-micro-test"]},"identifier":[{"system":"http://fhir.mimic.mit.edu/identifier/observation-micro-test","value":"8259514-90134"}],"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"laboratory"}]}],"code":{"coding":[{"system":"http://fhir.mimic.mit.edu/CodeSystem/microbiology-test","code":"90134","display":"EPSTEIN-BARR VIRUS VCA-IgM AB"}]},"subject":{"reference":"Patient/91e0e410-0782-5478-90e0-1bedc3aa1525"},"encounter":{"reference":"Encounter/4c6a16c0-9bc3-5f7a-8783-0d7693efbcfc"},"effectiveDateTime":"2115-09-28T13:08:00-04:00","valueString":"NEGATIVE <1:10 BY IFA.  INTERPRETATION: RESULTS INDICATIVE OF PAST EBV INFECTION.  In most populations, 90% of adults have been infected at sometime with EBV and will have measurable VCA IgG and EBNA antibodies. Antibodies to EBNA develop 6-8 weeks after primary infection and remain present for life. Presence of VCA IgM antibodies indicates recent primary infection.  ","specimen":{"reference":"Specimen/6c26de97-860f-5bd1-a597-b3aba2f6afba"}}